CANbridge Pharmaceuticals Inc.

SEHK:1228 Stock Report

Market Cap: HK$71.8m

CANbridge Pharmaceuticals Dividends and Buybacks

Dividend criteria checks 0/6

CANbridge Pharmaceuticals does not have a record of paying a dividend.

Key information

n/a

Dividend yield

-0.1%

Buyback Yield

Total Shareholder Yield-0.1%
Future Dividend Yield0%
Dividend Growthn/a
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Payout ration/a

Recent dividend and buyback updates

No updates

Recent updates

CANbridge Pharmaceuticals Inc. (HKG:1228) Not Doing Enough For Some Investors As Its Shares Slump 28%

Nov 14
CANbridge Pharmaceuticals Inc. (HKG:1228) Not Doing Enough For Some Investors As Its Shares Slump 28%

CANbridge Pharmaceuticals Inc. (HKG:1228) Stock Catapults 31% Though Its Price And Business Still Lag The Industry

Sep 27
CANbridge Pharmaceuticals Inc. (HKG:1228) Stock Catapults 31% Though Its Price And Business Still Lag The Industry

Lacklustre Performance Is Driving CANbridge Pharmaceuticals Inc.'s (HKG:1228) 28% Price Drop

Aug 07
Lacklustre Performance Is Driving CANbridge Pharmaceuticals Inc.'s (HKG:1228) 28% Price Drop

CANbridge Pharmaceuticals Inc.'s (HKG:1228) Share Price Boosted 56% But Its Business Prospects Need A Lift Too

Apr 23
CANbridge Pharmaceuticals Inc.'s (HKG:1228) Share Price Boosted 56% But Its Business Prospects Need A Lift Too

CANbridge Pharmaceuticals Inc.'s (HKG:1228) 26% Dip In Price Shows Sentiment Is Matching Earnings

May 05
CANbridge Pharmaceuticals Inc.'s (HKG:1228) 26% Dip In Price Shows Sentiment Is Matching Earnings

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if 1228's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if 1228's dividend payments have been increasing.


Dividend Yield vs Market

CANbridge Pharmaceuticals Dividend Yield vs Market
How does 1228 dividend yield compare to the market?
SegmentDividend Yield
Company (1228)n/a
Market Bottom 25% (HK)3.3%
Market Top 25% (HK)8.1%
Industry Average (Biotechs)1.1%
Analyst forecast (1228) (up to 3 years)0%

Notable Dividend: Unable to evaluate 1228's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate 1228's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate 1228's payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as 1228 has not reported any payouts.


Discover strong dividend paying companies